A Study Designed to Compare 2 Dose Strengths of TI Inhalation Powder in Adults With Type 1 Diabetes Mellitus and to Compare One of Those Formulations (30Units) With an Injection of Insulin Lispro

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

December 31, 2008

Conditions

Diabetes Mellitus: Type 1

Interventions

DRUG

Technosphere® Insulin Inhalation Powder

TI Inhalation Powder, two 15 U cartridges

DRUG

Technosphere Insulin® Inhalation Powder

TI Inhalation Powder, one 30 U cartridge

DRUG

RAA Population

RAA Population: All subjects received a single 10 IU sc injection of insulin lispro.

Trial Locations (2)

Diabetes & Glandular Disease Research Assoc PA, San Antonio

Profil Institute for Clinical Research Inc., Chula Vista